MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wafford, K. A.
Right arrow Articles by Kemp, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wafford, K. A.
Right arrow Articles by Kemp, J. A.

Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors

KA Wafford, CJ Bain, PJ Whiting and JA Kemp

Neuroscience Research Centre, Merck, Sharp & Dohme Research Laboratories, Harlow, Essex, UK.

The effect of benzodiazepines on the activity of gamma-aminobutyric acid (GABA)A receptors has been shown to be influenced by different alpha subunits and can also be affected by the presence of different gamma subunits. Previous studies have shown that receptors without a gamma subunit or those containing gamma 1 are modulated to a lesser degree by benzodiazepines. Using the Xenopus oocyte expression system to express different subunit combinations, a detailed analysis of the pharmacological modulation of GABAA receptors by various benzodiazepine site ligands has been carried out. We analyzed 14 compounds, varying through full agonist, partial agonist, antagonist, and inverse agonist, with receptors consisting of alpha 2 beta 1, alpha 2 beta 1 gamma 2S, and alpha 2 beta 1 gamma 1 and we demonstrate differences in their extent of potentiation by different benzodiazepine-type ligands. Most compounds showed negligible effects on alpha 2 beta 1 and most agonists, particularly the imidazopyridines zolpidem, alpidem, and AHR14,749, exhibited less potentiation with alpha 2 beta 1 gamma 1 than with alpha 2 beta 1 gamma 2S. The inverse agonists dimethoxy-4-ethyl- beta-carboline-3-carboxylate and Ro15-4513 did not act as inverse agonists and produced slight potentiation of alpha 2 beta 1 gamma 1 receptors. Concentration-response curves were constructed for five selected agonists to evaluate both affinity and efficacy differences between alpha 2 beta 1 gamma 2 and alpha 2 beta 1 gamma 1 receptors. Most compounds showed lower efficacy and up to 10-fold lower affinity with alpha 2 beta 1 gamma 1. Zolpidem showed slightly higher affinity but an extremely low efficacy; FG8205 also showed a markedly lower efficacy and was the most selective compound for alpha 2 beta 1 gamma 2S versus alpha 2 beta 1 gamma 1 receptors. CL218,872 showed high efficacy with alpha 2 beta 1 gamma 1 and affinity similar to that with alpha 2 beta 1 gamma 2 (being the least selective compound), suggesting that some low efficacy partial agonists with gamma 2-containing receptors may be more efficacious with gamma 1-containing receptors. The antagonists Ro15-1788 and CGS8216, although they blocked flunitrazepam potentiation of alpha 2 beta 1 gamma 2, could not block potentiation of alpha 2 beta 1 gamma 1. This study demonstrates that unique pharmacological profiles can be conferred by receptors containing different gamma subunits.

Volume 44, Issue 2, pp. 437-442, 08/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. Khom, I. Baburin, E. N. Timin, A. Hohaus, W. Sieghart, and S. Hering
Pharmacological Properties of GABAA Receptors Containing {gamma}1 Subunits
Mol. Pharmacol., February 1, 2006; 69(2): 640 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R.-Q. Huang and G. H. Dillon
Functional Characterization of GABAA Receptors in Neonatal Hypothalamic Brain Slice
J Neurophysiol, October 1, 2002; 88(4): 1655 - 1663.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. C. Harvey, K. L. Foster, P. F. McKay, M. R. Carroll, R. Seyoum, J. E. Woods II, C. Grey, C. M. Jones, S. McCane, R. Cummings, et al.
The GABAA Receptor alpha 1 Subtype in the Ventral Pallidum Regulates Alcohol-Seeking Behaviors
J. Neurosci., May 1, 2002; 22(9): 3765 - 3775.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-A. Thompson, P. B. Wingrove, L. Connelly, P. J. Whiting, and K. A. Wafford
Tracazolate Reveals a Novel Type of Allosteric Interaction with Recombinant gamma -Aminobutyric AcidA Receptors
Mol. Pharmacol., April 1, 2002; 61(4): 861 - 869.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Smith, L. Alder, J. Silk, C. Adkins, A. E. Fletcher, T. Scales, J. Kerby, G. Marshall, K. A. Wafford, R. M. McKernan, et al.
Effect of alpha Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant gamma -Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux
Mol. Pharmacol., April 16, 2001; 59(5): 1108 - 1118.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
H. L. June, S. C. Harvey, K. L. Foster, P. F. McKay, R. Cummings, M. Garcia, D. Mason, C. Grey, S. McCane, L. S. Williams, et al.
GABAA Receptors Containing {alpha}5 Subunits in the CA1 and CA3 Hippocampal Fields Regulate Ethanol-Motivated Behaviors: An Extended Ethanol Reward Circuitry
J. Neurosci., March 15, 2001; 21(6): 2166 - 2177.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. C. Jorge-Rivera, K. L. McIntyre, and L. P. Henderson
Anabolic Steroids Induce Region- and Subunit-Specific Rapid Modulation of GABAA Receptor-Mediated Currents in the Rat Forebrain
J Neurophysiol, June 1, 2000; 83(6): 3299 - 3309.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. M. Huntsman and J. R. Huguenard
Nucleus-Specific Differences in GABAA-Receptor-Mediated Inhibition Are Enhanced During Thalamic Development
J Neurophysiol, January 1, 2000; 83(1): 350 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. J. Delaney and P. Sah
GABA Receptors Inhibited by Benzodiazepines Mediate Fast Inhibitory Transmission in the Central Amygdala
J. Neurosci., November 15, 1999; 19(22): 9698 - 9704.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. P. Bonnert, R. M. McKernan, S. Farrar, B. le Bourdelles, R. P. Heavens, D. W. Smith, L. Hewson, M. R. Rigby, D. J. S. Sirinathsinghji, N. Brown, et al.
theta , a novel gamma -aminobutyric acid type A receptor subunit
PNAS, August 17, 1999; 96(17): 9891 - 9896.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. T. Nett, J. C. Jorge-Rivera, M. Myers, A. S. Clark, and L. P. Henderson
Properties and Sex-Specific Differences of GABAA Receptors in Neurons Expressing gamma 1 Subunit mRNA in the Preoptic Area of the Rat
J Neurophysiol, January 1, 1999; 81(1): 192 - 203.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Huntsman, B.-V. Tran, S. G. Potkin, W. E. Bunney Jr., and E. G. Jones
Altered ratios of alternatively spliced long and short gamma 2 subunit mRNAs of the gamma -amino butyrate type A receptor in prefrontal cortex of schizophrenics
PNAS, December 8, 1998; 95(25): 15066 - 15071.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Sur, K. Quirk, D. Dewar, J. Atack, and R. McKernan
Rat and Human Hippocampal alpha 5 Subunit-Containing gamma -Aminobutyric AcidA Receptors Have alpha 5beta 3gamma 2 Pharmacological Characteristics
Mol. Pharmacol., November 1, 1998; 54(5): 928 - 933.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
R. M. McKernan, S. Farrar, I. Collins, F. Emms, A. Asuni, K. Quirk, and H. Broughton
Photoaffinity Labeling of the Benzodiazepine Binding Site of alpha 1beta 3gamma 2 gamma -Aminobutyric AcidA Receptors with Flunitrazepam Identifies a Subset of Ligands that Interact Directly with His102 of the alpha  Subunit and Predicts Orientation of These within the Benzodiazepine Pharmacophore
Mol. Pharmacol., July 1, 1998; 54(1): 33 - 43.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. Allan, H. Wu, L. L. Paxton, and D. D. Savage
Prenatal Ethanol Exposure Alters the Modulation of the gamma -Aminobutyric AcidA Receptor-Gated Chloride Ion Channel in Adult Rat Offspring
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 250 - 257.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Skolnick, R. J. Hu, C. M. Cook, S. D. Hurt, J. D. Trometer, R. Liu, Q. Huang, and J. M. Cook
[3H]RY 80: A High-Affinity, Selective Ligand for gamma -Aminobutyric AcidA Receptors Containing Alpha-5 Subunits,
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 488 - 493.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
P. B. Wingrove, S. A. Thompson, K. A. Wafford, and P. J. Whiting
Key Amino Acids in the gamma  Subunit of the gamma -Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site
Mol. Pharmacol., November 1, 1997; 52(5): 874 - 881.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Belelli, J. J. Lambert, J. A. Peters, K. Wafford, and P. J. Whiting
The interaction of the general anesthetic etomidate with the gamma -aminobutyric acid type A receptor is influenced by a single amino acid
PNAS, September 30, 1997; 94(20): 11031 - 11036.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Nadeson and C. S. Goodchild
Antinociceptive Properties of Propofol: Involvement of Spinal Cord gamma -Aminobutyric AcidA Receptors
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1181 - 1186.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
E. Sanna, A. Murgia, A. Casula, and G. Biggio
Differential Subunit Dependence of the Actions of the General Anesthetics Alphaxalone and Etomidate at gamma -Aminobutyric Acid Type A Receptors Expressed in Xenopus laevis Oocytes
Mol. Pharmacol., March 1, 1997; 51(3): 484 - 490.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics